Integrated Analysis of Molecular and Clinical Prognostic Factors in Stage II/III Colon Cancer

Abstract

Concomitant assessment of molecular and clinical markers in multivariable analysis is essential to confirm or refute their independent prognostic value. Including molecular markers with independent prognostic value might allow more accurate prediction of prognosis than TNM staging alone.